Axon Enterprise, Inc. (NASDAQ:AXON) CRO Sells $2,222,280.00 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) CRO Cameron Brooks sold 3,000 shares of the stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $740.76, for a total value of $2,222,280.00. Following the completion of the transaction, the executive now directly owns 19,447 shares of the company's stock, valued at $14,405,559.72. This represents a 13.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Axon Enterprise Trading Up 0.2%

Shares of AXON stock traded up $1.72 during mid-day trading on Friday, hitting $790.08. The company's stock had a trading volume of 49,973 shares, compared to its average volume of 727,845. The company's fifty day simple moving average is $638.88 and its 200-day simple moving average is $615.19. Axon Enterprise, Inc. has a 52 week low of $278.24 and a 52 week high of $795.18. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $61.51 billion, a PE ratio of 204.16, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period last year, the company posted $1.15 EPS. The business's quarterly revenue was up 31.3% on a year-over-year basis. As a group, equities research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Axon Enterprise

Hedge funds have recently added to or reduced their stakes in the stock. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $30,000. TCTC Holdings LLC boosted its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after purchasing an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC boosted its holdings in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise in the first quarter worth about $32,000. Finally, Banque Transatlantique SA bought a new position in Axon Enterprise in the first quarter worth about $31,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on AXON shares. Bank of America raised their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Needham & Company LLC raised their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group raised their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $699.55.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.